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activity; however, the genetic and molecular basis of this regulation in humans is not well understood because access to this tissue is a major barrier and available only postmortem. Although rodent models are useful for a broad understanding of hypothalamic regulation, genetic risk for associated disorders such as diabetes and obesity may be human-specific and therefore require human models to identify the molecular mechanism. Recent meta-analyses of genome-wide association studies (GWAS) aiming to identify genetic risk for measures of obesity in diverse populations show the majority to be located in noncoding and potentially regulatory regions that are not conserved between mice and humans (8) (9) (10) (11) . Moreover, genes in proximity to genetic variants associated with body mass index (BMI), a common clinical measure of obesity, were strikingly over-represented in the processes of hypothalamic function, neuronal transmission and development (8) (9) (10) (11) . Because of metabolic and genetic regulatory differences between humans and rodent models, it is important to investigate the role of these variants on hypothalamic and neuronal function in human context. Additionally, growing evidence from maternal programming paradigms has emphasised the critical importance of proper hypothalamic neuronal development in maintaining energy homeostasis (12) (13) (14) . Therefore, genetic variants that impact on traits influencing energy homeostasis such as obesity may manifest their effects early in hypothalamic development, which occurs largely in utero in humans.
To overcome the barrier of limited access to tissue for study, we have developed protocols to generate human-induced pluripotent stem cell (hiPSC)-derived neuronal cultures that recapitulate many of the features of hypothalamic neurones from the arcuate nucleus. We have also benchmarked this in vitro model to in vivo events that are pivotal in hypothalamic development using isoform switching information. To further confirm the utility of our model in uncovering mechanisms faithful to the hypothalamus, we compared gene expression patterns of iPSC-derived hypothalamic cells with adult hypothalamus gene expression reported in the Genotype-Tissue Expression database (GTEx) (15) . This benchmarking revealed that our terminally differentiated cultures manifest gene expression patterns closely mirroring that of adult hypothalamus compared to any other brain region. Furthermore, our human model provides a unique window for exploring the impact of genetic variants on changes in the hypothalamus in a neuronal stage-specific manner. We have performed a longitudinal analysis of expression profiles of control human iPSC-derived neurones to examine co-regulation of biological processes and potential control by microRNA (miRNA) across development and maturation. With these data, we have identified distinct developmental expression patterns of obesity GWAS-implicated genes and potential regulators that may be involved in neuronal influence on BMI.
Materials and methods
Human iPSC generation and characterisation is described in full in the Supporting information (Appendix S1 and Fig. S1 ). Briefly, human newborn fibroblasts (ATCC CRL-2703) were reprogrammed using episomal vectors expressing the transcription factors C-MYC, OCT4 (POU5F1), SOX2, NANOG and KLF4.
Neuronal differentiation
The verified hiPSC from passage 15 were dissociated and grown as cellular aggregates or embryoid bodies (EBs) on ultra-low attachment six-well plates in low insulin-modified hES medium without basic fibroblast growth factor FGF for 4 days, Neural induction medium (NIM) containing Dulbecco's modified Eagle's medium/F12, supplemented with 1 9 N2, 0.1 mM non-essential amino acids (NEAA), 4 lg/ml heparin was then supplied for 2 days. On day 6, the EB aggregates were transferred to dishes coated with a combination of poly-L-ornithine and laminin and fed fresh NIM every other day. Primitive neuroepithelial (NE) cells appeared at day 8-10 and were treated with 50 ng/ml WNT3A in NIM. On day 14-17, neural tube-like rosettes were formed and the rosettes were then isolated and transferred onto new coated dishes and grown in NIM containing WNT3A 50 ng/ml for 5-10 days, dissociated with Accutase (Innovative Cell Technologies, Inc., San Diego, CA, USA) and re-plated onto coated dishes in neuronal differentiation medium containing reduced insulin neurobasal medium (16), 1 9 N2 and 2 9 B27, 0.1 mM NEAA and then supplemented with 1 lM cAMP and 10 ng/ml WNT3A for 3 days. The neurones were then maintained in this medium supplemented with brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor and insulin-like growth factor 1 (10 ng/ ml each).
Immunocytochemical characterisation of human neurones
The differentiated neurones were harvested and transferred to poly-Lornithine/laminin-coated glass coverslips for immunostaining with a combination of neuronal-specific markers: anti-beta III tubulin (catalogue number ab7751; Abcam, Cambridge, MA, USA); anti-PAX6 (catalogue number ab78545; Abcam); anti-VGLUT1 (vesicular glutamate transporter1) (catalogue number ab72311; Abcam); anti-GRM3 (glutamate receptor, metabotropic-3) (catalogue number ab188750; Abcam); anti-MAP2 (microtubule-associated protein-2) (catalogue number ab11267; Abcam); anti-AGRP (agouti-related peptide) (catalogue number 113481; Abcam); anti-VGAT (vesicular GABA transporter, VIAAT) (catalogue number 131 002; Synaptic Systems GmbH, G€ ottingen, Germany); anti-NPY (neuropeptide Y) (catalogue number 028-08-02; Thermo Fisher Scientific Inc., Waltham, MA, USA); and anti-GLP1R (glucagon-like peptide 1 receptor) (catalogue number ab39072; Abcam).
Flow cytometry
Day 70 neuronal cultures were dissociated with Accutase, washed once in neurobasal medium and 2 9 10 6 cells aliquoted for each assay. Cells were washed and resuspended in 1 ml protein/serum free phosphate-buffered saline (PBS). A fixable viability dye (Ghost dye Violet 510; Tonbo Biosciences, San Diego, CA, USA) was used to discriminate dead cells with minor modifications from the manufacturer's instructions to accommodate primary neurones. Briefly, 1 ll of 1 : 5 diluted Ghost dye was added to each 1 ml of cell suspension, vortexed and incubated for 10 min at room temperature protected from light. 
Neuronal expression profiling
Total RNA at nine time points from days 0-115 during the differentiation and maturation process was isolated using Qiagen RNeasy kit (Qiagen, Valencia, CA, USA) and quality control assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, USA 
Physiological verification of neurones
Functioning adiponectin and leptin receptors were assessed by changes in NPY expression in response to adiponectin/aCrp30 and leptin treatment: approximately 75-day neuronal cultures were held in neuronal maintenance medium free of insulin and at 5.5 mM glucose 24 h and then supplemented with either 1 lg/ml recombinant human adiponectin/aCrp30 or 50 nM recombinant human leptin (R&D Systems, Minneapolis, MN, USA). Cells in 24-well plates were collected at 4 h of exposure and RNA was isolated for expression analysis using qRT-PCR as described above and using 18SRNA for normalisation. Four independent neuronal cultures derived from two iPSC were tested in triplicate. A two-tailed t-test was used to determine Pvalues. The sequences for the primer pairs used are given in the Supporting information (Table S1 ). Functioning glutamate receptors were assessed by patch clamp as described in the Supporting information.
Statistical analysis

Differential transcriptomics
Data generated from GENOMESTUDIO (Illumina) were pre-processed by log2 transformation and quantile normalisation implemented in the lumi R package (17) . Differential expression analysis was carried out with the Limma package implemented in R (18) . A sample relationship during time progression was constructed using a multidimensional scaling algorithm. A K-means cluster algorithm was applied to identify gene clusters that follow similar patterns during progression from days 35 to 115. Transcripts with significant differential expression (adjusted P-value < 0.01, absolute fold change > 2) between at least two time points were included in the analysis. The Calinski and Silhouette indices were evaluated to identify optimum number of clusters for k-means algorithm. Then, for each cluster, gene ontology (GO) and enrichment analysis for miRNAs and transcriptional factors were carried out using TOPPGENE (19) , DAVID (20) and FIRE (21 
Comparison with GTEx data
Raw data (.CEL files) of all brain tissue originated samples from GEO database (GSE45878) were downloaded and pre-processed using the oligo package in R (22) . Probes that map to multiple genes were discarded from further analyses. Potential batch effects between our hiPSCs and GTEx samples were removed by using the sva package in R (23) . Sample relationships between hiPSCs from the present study and brain tissues from the GTEx project were examined using principal component analysis. Hierarchical clustering based on average linkage was also carried out using genes that met the criteria of the coefficient of variation above the second quantile, average gene expression above the second quantile and SD above the second quantile.
Results
The derived neuronal cultures were characterised via transcriptomics and verified using immunocytochemistry with specific neuronal markers. Total RNA for two samples at each of nine time points, as well as from the source human fibroblast cells, was assayed with HT-12 v4 Beadchips. Following standardisation steps, 34 694 unique probes representing 15 631 genes were robustly detected and their expression compared across the multiple time points. The neuronal differentiation protocol and the corresponding time points for expression analyses are shown in Fig. 1(A) . A heatmap of the expression profiles for the genes of moderate to high expression that were differentially expressed across at least one time point is shown in Fig. 1 (B). Distinctive expression profiles were observed for the time points before and after day 35 as expected since day 35 marks the earliest differentiated neurones. The results from multidimensional scaling of mRNA and miRNA expression profiles between each time point are plotted in Fig. 2 . Similar relationships are seen for both mRNA and miRNA temporal profiles, including a similar progression from days 35-115, suggesting capture of miRNA regulation during differentiation and maturation. The GEO accessions for the mRNA and miRNA datasets are GSE78789 and GSE78812, respectively. qRT-PCR and western blotting verification and characterisation was conducted on a subset of genes as shown in the Supporting information (Fig. S2 ). The hypothalamic ARC contains several distinct neuronal populations, including the orexigenic NPY/AGRP-expressing neurones, the anorexigenic pro-opiomelanocortin (POMC)-expressing neurones, and dopaminergic, catecholaminergic and growth hormone-releasing hormone (GHRH) neurones. The profiles of the mature iPSC-derived neurones indicate that they are primarily NPY/AGRP neurones. In addition to NPY, the glutamate transporters SLC17A6 (VGLUT2) and SLC17A7 (VGLUT1), the metabotropic glutamate receptors GRM2 and GRM3, and the GABA vesicular transporter SLC32A1 (VGAT) and GABA B receptors (24) are among the highly expressed genes, whereas no expression is observed for the dopamine transporter gene SLC6A3 (DAT1), the norepinephrine transporter SLC6A2 (NET), the serotonin transporter SLC6A4 (SERT), the vesicular monoamine transporters SLC18A1 and SLC18A2 (VMAT1 and VMAT2), and POMC or MC4R. The transcription factors archaete-scute complex 1 (ASCL1) and POU class 3 homeobox 2 (POU3F2) were highly expressed by early neurones. In mice, ASCL1 promotes the proliferation of NPY/AGRP, GHRH and catecholaminergic neurones of the ARC (25) . Importantly, GHRH is not expressed by our iPSC-derived neurones and, as stated above, nor are the catecholamines NET and DAT1. High levels of adiponectin receptors 1 and 2 (ADIPOR1 and ADIPOR2), as well as leptin receptor (LEPR), were detected in the differentiated neurones. No expression of oligodendrocyte-specific markers or the astrocyte marker glial fibrillary acidic protein (GFAP) was detected (see Supporting information, Fig. S4 ). Immunocytochemical analyses show strong expression and co-localisation of AGRP and NPY in the cultures and confirm the expression of key proteins such as VGAT, GLP1R (26) and metabotropic glutamate receptor 3 (Fig. 3) . Furthermore, we conducted flow cytometric analyses of neurones using indirect immunofluorescent staining for NPY and AGRP on three independent neuronal cultures under standard nonfasting conditions similar to that used for transcriptomic profiling. We observed between 93% and 96% of the cells to be positive for NPY, and a total of 80% to be double positive for NPY and AGRP ( Fig. 3G ; see also Supporting information, Fig. S3 ). Less than 0.5% of cells were positive only for AGRP, as expected. AGRP expression in NPY neurones is increased by fasting conditions and therefore it is possible that a greater number of the NPY positive neurones would also express measureable AGRP if tested under a fasting-like state. Taken together, the differentiation method that we used results in neurones with a profile similar to the ARC orexigenic neurones expressing NPY and AGRP.
To further confirm the utility of our model in representing specific neurones of the hypothalamus, we compared gene expression patterns of iPSC-derived hypothalamic cells with adult brain region-specific gene expression reported in the GTEx. Principal components analyses of GTEx gene expression data for 103 samples from 13 brain regions, as well as expression profiles from each post-neuronal induction time point for the iPSC-derived neurones, indicate that the expression profiles of our derived neurones most closely correlate with data from hypothalamic samples (Fig. 4A) . Next, we performed hierarchical cluster analyses using all GTEx spinal cord and hypothalamic samples and all time points for the iPSC-derived neurones. The results and dendogram (Fig. 4B) indicate that the neurones generated are more similar to hypothalamic tissues compared to the spinal cord. The correlation with hypothalamic samples does not completely overlap as expected because the GTEx hypothalamic tissue samples include many non-neuronal cell types as well.
Physiological testing of neuronal cultures
The functionality of these hypothalamic-like neurones was confirmed using the neuropeptide response to external hormonal stimuli and patch-clamp recordings. Several studies have demonstrated hormonal regulation of peptide expression in NPY/AGRP neurones of the arcuate nucleus in relation to obesity whereby adiponectin increases and leptin decreases NPY expression and secretion. Following treatment of our neurones with either 1 lg/ml recombinant human adiponectin/aCrp30 or 50 nM recombinant human leptin in 5 mM glucose-containing media, we observed a significant > 2-fold increase and 1.6-fold decrease, respectively, of NPY mRNA (Fig. 5) .
Although an indirect effect of treatment cannot be ruled out, these results suggest that the cells are expressing functioning adiponectin and leptin receptors. Next, because glutamatergic input to NPY/ AGRP neurones of the ARC plays a key role in controlling energy balance (27), we used whole-cell recordings of 75-day neurones to confirm the presence of functioning glutamate receptors in the cultures as shown in the Supporting information (Fig. S5 ).
Co-regulation of genes, miRNAs and pathways across neuronal maturation
To examine the potential co-regulation of genes involved in distinct biological processes during maturation of human neurones, a Kmeans clustering algorithm was applied to the normalised expression values for days 35-115. Twelve clusters, or genesets, best represented the time course data across the neuronal maturation phase. Of the 15 631 genes expressed by these neurones, only 4079 showed distinct patterns of temporal expression changes (Fig. 6 ). For each gene cluster, we examined geneset enrichment for known biological processes and GO terms, as well as predicted miRNA and transcription factor enrichment. Full GO results and miRNA correlation for each gene cluster are provided in the Supporting information (Tables S1 and S2 ). The results for clusters of particular note in relation to metabolism are described below. We also assessed the potential co-regulation of miRNAs across neuronal maturation by applying a K-means clustering algorithm separately to the normalised expression values of miRNA measured with RNAseq for days . Of the 1206 miRNA expressed by these neurones at any time point, 199 met the criteria of being significantly differentially expressed between at least two time points, and six clusters best represented the time course data for these potentially developmentally expressed miRNAs across the neuronal maturation phase (see Supporting information, Fig. S6 ). Detailed data for each miRNA cluster and predicted gene targets are provided in the Supporting information (Tables S3 and S4) . Cluster 1 contains genes whose normalised expression sharply increases across early development, peaking at day 75, and then rapidly declines to that of early neurones. Key GO terms enriched in this cluster are 'neurone projection', 'synapse' and 'transmission of nerve impulse' (P = 3.9 9 10 -8 , 1.1 9 10 -7 and 7.7 9 10 -3 ).
Many genes in this cluster are targets of the repressor Polycomb protein SUZ12 in human embryonic stem cells (P = 1.54 9 10 -10 ) and a significant number of genes have MAM (meprin/A5-protein/ PTPmu) protein domains (P = 6 9 10 -5 ), including MDGA2, which interacts with neuroligin 2 to regulate inhibitory synapse development (28), neuropilin 1 (NRP1), which regulates dendritic growth and branching, and the ALK receptor tyrosine kinase, which induces neurite outgrowth (29) . Predicted binding sites for miR96-5p, a miRNA with diurnal activity and evidence for involvement with circadian rhythm regulation (30, 31) , was the most significantly enriched in our data (P = 7.4 9 10 -5 ) and showed negative coexpression with its putative targets (r = À0.76, P = 0.01). Significant enrichment and positive correlation with expression of miR-9 and negative correlation for miR-181a (enrichment P = 0.009 and 0.006; correlation r = 0.97 and À0.93; P = 4 9 10 -6 and 1 9 10 -4 , respectively) was also found, reflecting the biological process of specific synapse development for this cluster. Whereas, mir-9 targets the 3 0 -UTR of dopamine receptor D2 and results in its downregulation, mir-181a promotes the generation of neurones of dopaminergic fate (32, 33) . Cluster 3 genes are similar in temporal profile to cluster 1 but show much stronger differential expression between early and late stages of neuronal development and are dominated by those containing a homeobox domain (2.6 9 10 -28 ) such as IRX3. The obesity-associated intronic interval of the fat mass and obesity associated (FTO) gene harbours an enhancer for IRX3 in adipocytes (34) and the embryonic mouse hypothalamus (35) . Furthermore, IRX3 deficient mice show a significant reduction in body weight via an increase in basal metabolic rate and browning of white adipose tissue and, in addition, knockout of IRX3 specific to either the hypothalamus or adipocytes recapitulates a significant portion of the phenotype, indicating potential cell autonomous roles for adipocytes and hypothalamic neurones, which, together, influence obesity. Roles involved in regionalisation and pattern-specific processes are enriched in this cluster of genes, including many from the ROBO and SLIT families as well as netrin 1 (NTN1), which are genes that are central to the directional guidance of axons during the establishment of neural circuitry. In mice, the outgrowth of NPY neurites from the ARC was observed to be impaired in offspring of obese mothers compared to those from non-obese mothers, and genes from the ROBO and SLIT families, as well as receptors for NTN1, had altered expression in the ARC at midgestation in the affected offspring (13) . Thus, this cluster may provide information regarding the critical developmental window in this in vitro model that relates to understanding how the in utero environment might affect foetal programming and susceptibility to metabolic disorders via neuronal development. Several miRNAs are predicted to target genes of this cluster and also showed significant correlation of expression values with their targets in our human neurones (see Supporting information, Table S2 ); however, their function in hypothalamic development is still unknown. By contrast, cluster 5 genes, whose expression sharply increased across late maturation stages, are enriched for 'actin-myosin filament sliding and 'axonogenesis' processes, the GO terms 'extracellular matrix' and 'cell adhesion', as well as targets of MEF2A (P = 2.1 9 10 -7 ), a transcription factor that affects dendrite development and plasticity during CNS neural circuit formation (36).
Motor proteins have been shown to have various neuronal functions, including cell migration, growth cone motility and axonal transport. It is interesting to note that three (MYL1, MYLPF, TNNC2) of the five myosin cytoskeletal protein genes shown to have increased hypothalamic expression after glucocorticoid treatment in mice (37) are contained in cluster 5. Whether these changes play a role in glucocorticoid-induced hypothalamic leptin resistance and weight gain is not known. Binding sites for miR132 and miR219, which are two microRNAs involved in circadian clock modulation (38) , were significantly over-represented in cluster 5 (P < 0.05); however, the expression of these microRNAs was not significantly 75  115  35  75  115  35  75  115  35  75  115   35  75  115  35  75  115  35  75  115  35  75  115   35  75  115  35  75  115  35  75  115  35 ). Because calcium signalling is critical for proper dendritic arborisation (39) and neurotransmitter release, coordinated temporal expression of calcium ion channels and molecules involved in cross-talk between calmodulin and cAMP pathways may be needed for appropriate neuronal development and function.
Cluster 8 genes comprise those involved in 'multicellular organismal signalling' (P = 9 9 10 -8 ) and 'dendrite' (P = 4 9 10 -11 ). Several genes encoding GABA receptors, glutamate receptors and those found in neurite growth cones belong to this cluster. Predicted targets of miR218-5p are enriched in cluster 8 (P = 8E-3) and the expression of this miRNA was significantly positively correlated with that of genes of this cluster (r = 0.94; P = 6 9 10 -6 ). This micro-RNA has been shown to localise to dendrites and to negatively regulate ROBO1 and ROBO2 expression yet be positively correlated with NRXN1, suggesting a role in refinement of synaptic connections (40) . The positive correlation of mIR218-5p expression with genes of this cluster may be unexpected; however, miR218 is reported to be one of a group of miRNAs that are co-expressed with their target genes and either spatially or temporally modulate their protein levels after miRNA inhibition release via extracellular stimuli such as BDNF (41) . Geneset enrichment analyses for genes comprising cluster 7, which are highly expressed by early neurones across days 35-55 and then consistently decreased in expression across each consecutive time point, indicated significant enrichment for the biological processes 'tube development' and 'negative regulation of cell differentiation' (P-value range 1.1 9 10 -8 to 7.4 9 10 -7 ). The FIRE results
showed genes in this cluster to be enriched for targets of MZF1 (P < 0.05), a transcription factor known to induce cell proliferation (42) . This gene cluster appears to be regulated by the miRNA let7b as shown by binding site enrichment (P = 3.9 9 10 -6 ), as well as a significant negative correlation of expression of let7b with that of this cluster (r = À0.99; P = 1.1 9 10 -8 ). Surprisingly, the GO term 'abnormal foetal growth/weight/body size' was significantly represented in the cluster by 12 genes (P = 2.6 9 10 -6 ) including several imprinted genes such as delta-like 1 homologue (DLK1) known to co-localise with AGRP/NPY and be involved in hypothalamic development (43) . Cluster 11 genes are distinct in that their transcript levels rise steeply in the mature neuronal cultures at day 115. Genes coding for components of the ribonucleoprotein complex are enriched in this cluster (P = 3.1 9 10 -10 ) and their increase in expression in the late stage neurones may correspond to the packaging and transport of mRNAs to the dendrites and synapses. Genes involved in cellular respiration and translation, such as many encoding mitochondrial ribosomal proteins, also belong to this cluster. The sensing of nutrients by the hypothalamus may involve mitochondrial respiration (44) and studies suggest that lipid metabolism and mitochondrial free radical production in NPY/AGRP neurones of the ARC are key factors in the regulation of appetite. Ghrelin-induced food intake was shown to require uncoupling protein 2 (UCP2)-dependent mitochondrial proliferation and activation of these specific hypothalamic neurones (45) . Thus, the late-stage iPS-derived neuronal cultures may be a good model for study of the mitochondria-mediated effects of signalling proteins on appetite and behaviour in human context.
Benchmarking in vitro neuronal development to in vivo development
To determine which in vivo developmental time points are represented by the neuronal culture maturation time points, we used isoform switching information for three key genes. The gene transcription factor 7-like 2 (TCF7L2) undergoes brain developmental alternative splicing. In mouse late embryonic thalamus, two predominant isoforms are observed at 35 and 58 kDa and an isoform at 78 kDa is also detected; however, expression of the 35-kDa form is greatly reduced at postnatal day 10 and barely detectable at day 60 (46) . Similar to mouse, we see 35-, 58-and weak 75-kDa TCF7L2 isoforms early in the human neuronal cultures. From days 75-115, only 58 kDa and 75 kDa are expressed (see Supporting information, Fig. S2 ). Furthermore, overall expression of TCF7L2 is much lower in the mature neurones at days 95-115, which is consistent with the data reported for postnatal mouse. In addition, the vesicular glutamate transporter isoforms VGLUT1 and VGLUT2 are developmentally regulated. In rat, VGlut1 and VGlut2 are moderately expressed across gestation but, after birth, there is a marked increase in VGlut1 and a decrease in VGlut2 expression (47) . Similarly, glycine receptor isoforms switch from the neonatal alpha2 subunit to the adult alpha1 and beta subunits by the second postnatal week in mice (48) . Consistent with this, we observe a striking switch in the expression of these developmentally regulated genes in the neuronal cultures beginning at day 95 (see Supporting information, Fig. S7 ). Taken together, these data suggest that the neuronal culture time points of days 95 and 115 may represent in vivo postnatal stage neurones in the mice and rat.
Temporal expression changes of obesity GWAS-implicated genes
Using GWAS data from Locke et al. (8) , we aimed to determine whether genes implicated by GWAS were associated with BMI shared temporal expression patterns during hypothalamic development. First, we identified the genes nearest the GWAS-reported SNPs (n = 289) from Locke et al. (8) that reached BMI association significance of P < 1 9 10 -5 . A total of 58 of these GWAS-implicated genes that were expressed by GTEx hypothalamus (out of 203) show distinct temporal expression patterns represented by our 12 clusters giving significant evidence of enrichment with P = 3.7 9 10 -7 . We also tested whether this set of genes was enriched in any particular cluster. Cluster 1 described above and in Fig. 6 was significantly enriched for GWAS-implicated genes (P = 3.3 9 10 -7 , > 5-fold enrichment). Additionally, six of the 14 GWAS-implicated genes that are present in cluster 1 are predicted by both PICTAR and TARGETSCAN to be targets of mir-96 (Table 1) , which may be involved in circadian rhythm modulation (30) . Nominal enrichment was seen for clusters 4 and 5 (P = 0.02 and 0.03, respectively). Given that trait-associated genetic variants may exert long-range regulatory effects, we also conducted an enrichment test by considering all genes located within 250 kb of the index SNPs. Of the 1122 hypothalamic-expressed genes in this interval, 231 belong to our gene clusters with significant enrichment evidence of P = 3 9 10 -6 . Cluster 1 remained enriched but with attenuated significance (P = 0.010). Detailed results are given in the Supporting information (Table S5 ). For comparison, we conducted a similar analyses using GWAS data from Shungin et al. (49) for waist hip ratio (WHR) as a proxy for body fat distribution. Associated loci for this trait have been shown to be enriched for genes expressed in adipose tissue and the processes of adipogenesis, angiogenesis and insulin resistance. None of the 12 clusters were significantly enriched for genes proximal to the 61 loci with reported GWAS significance of P < 1 9 10 -5 for WHR (cluster enrichment P ≥ 0.6). In addition, no clusters were significantly enriched for genes within 250 kb of the WHR loci. Nominal enrichment (P = 0.013) was seen for cluster 3; however, six of the seven genes in this cluster were members of the homeobox A cluster near a single GWAS locus on chromosome 7, which confounds the enrichment.
Discussion
The importance of hypothalamic neural signalling in the regulation of energy homeostasis has been established via animal studies, as well as rare and severe, monogenic disorders of human obesity.
The orexigenic AGRP/NPY neurones of the ARC regulate food intake and the behaviours associated with this mission. Several rodent studies have linked the release of AGRP, NPY and GABA by these neurones with changes in energy balance. The study of these key neurones in humans, however, is extremely limited by tissue access. We have developed a protocol to generate cultures of neurones from human iPSC that recapitulate many of the features of these important hypothalamic neurones. Our protocol, which uses low-insulin modified hES media without basic fibroblast growth factor, incorporates the findings from Wataya et al. (16) showing that minimisation of exogenous signals in ES media induces rostral hypothalamic differentiation. Unlike Wataya et al. (16) , our protocol includes treatment of the resulting self-patterned purified neural precursors with Wnt. The early neural progenitors then express high levels of a number of proneural genes critical for hypothalamic development and known to be repressed by the Notch signalling pathway, including the transcription factor ASCL1, which is key to ARC development (50, 51) . Two other groups have developed mixed cultures of hypothalamic neurones expressing POMC, NPY, AGRP, somatostatin, dopamine, melaninconcentrating hormone and vasopressin using a directed differentiation protocol via early activation of SHH signalling and dual SMAD inhibition followed by inhibition of Notch signalling (52, 53) . Thus, our protocol, which combines aspects of these self-patterning and directed approaches, is unique in that the derived cultures are less heterogeneous and consist mainly of NPY/AGRP neurones. Recent data also suggest that common genetic variation influencing body weight regulation may exert their effects via the CNS and especially the hypothalamus. Neither the cellular effects of these risk genetic variants, nor the developmental timing of these events is yet known. Using the developmental expression profiles from human hypothalamic-like neuronal cultures that we have generated from iPSC, we have defined sets of potentially co- regulated genes that exhibit distinct, and intrinsic dynamic expression patterns across neuronal stages. One distinct set of temporally expressed genes consisting of < 2% of the total neuronal genes is strikingly enriched for genes that have been implicated by GWAS to be associated with body weight regulation and obesity. This set of genes, which, by GO analysis, are involved in 'neuron projection', 'synapse' and 'transmission of nerve impulse', exhibits a temporal expression pattern that sharply peaks in midstage neurones and then plateaus at a much reduced level in the mature neurones corresponding to those in mice at approximately 1 month of age. Many of these genes are predicted targets of miR-96, a microRNA with a significant inverse expression pattern and one with growing evidence for regulation of (and by) circadian factors. This hints that these GWAS obesity candidates might be influenced by circadian rhythm; however, these in silico miRNA predictions need to be confirmed experimentally. This relationship is an intriguing finding because the fat mass and obesity associated gene FTO has been shown to modulate circadian rhythms (54) and variation in genes related to the circadian rhythm of food intake and hypothalamic signalling have been associated with extreme obesity (55) . The developmental expression pattern observed by these GWASimplicated genes in our hypothalamic neuronal cultures suggests that their influences on body weight regulation may occur during early development. This is consistent with findings reported by both Smemo et al. (35) and Claussnitzer et al. (34) with regard to FTO intronic variants. The chromatin looping between the FTO intronic region and IRX3, as well as the effect of associated SNPs on expression of IRX3 and IRX5, was only observed in embryonic brain and differentiating adipocytes, respectively, and not in the mature tissue. In our model, high levels of gene expression of IRX3 and IRX5 are observed only in the early neurones with little to no expression detected in the later stage neurones. Whether the obesity causal risk variants exert effects through IRX3/IRX5 in the hypothalamus in humans is not known. A recent study has described allelic-based differential expression of FTO and the proximal gene retinitis pigmentosa GTPase regulator-interacting protein-1 like (RPGRIP1L), but not IRX3 or IRX5, in early neurones derived from human iPS cells using a dual-SMAD inhibition protocol (56) . Such results suggest that the molecular mechanism for the risk variants involves RPGRIP1L and FTO rather than the IRX gene family in the hypothalamus; however, it is important to note that the early neurones studied were not representative of the hypothalamus. Moreover, expression of IRX3 and IRX5 was very low at the time point studied, and thus the pertinent time point may have been missed. Further studies in hypothalamic-specific models may be needed to resolve these findings. The results from these and similar studies highlight a need to study obesity GWAS variants during relevant cellular or tissue development because their effects may not be observed in adult tissue biopsies or post-mortem samples, for example.
Because hypothalamic developmental processes occur in utero in humans, this accessible in vitro human model will be useful to begin to understand how alterations of these genes affect neuronal development and/or plasticity and ultimately pathophysiology underlying obesity susceptibility. Additionally, these neurodevelopmental processes may occur in a similar fashion during adult hypothalamic neurogenesis, which is necessary for the response of energy-balance circuits to environmental challenges, yet declines with age. Determining the genetic and molecular events of this highly controlled process in these key hypothalamic neurones may help to uncover drivers serving as targets for interventions on body weight and appetite regulation.
Our temporal profiling results also point to a critical developmental window in this in vitro human model that can be exploited for study of in utero environmental effects on foetal programming and susceptibility to metabolic disorders via alterations in neuronal development. In animal models of maternal obesity, the outgrowth of NPY/AGRP neurites from the ARC to the PVN is impaired, and this may be a consequence of altered expression of genes involved in directional guidance of axons during development (13) . We show that these genes are highly expressed in early neurones, demonstrate peak expression at or near a time point that correlates with the end of gestation in rodents and then show minimal expression in late-stage neurones. Whether similar changes in gene expression and hypothalamic neurite connections from the ARC occur in humans in response to adverse intrauterine environments is not known. This model can be useful for such studies.
In conclusion, we have developed an in vitro human system for the study of NPY/AGRP neurones of the arcuate nucleus. Although complex neural network interactions cannot be studied using this in vitro system, this human model provides a unique tool for examining the molecular and cellular effects of genetic variation in a neuronal-stage specific manner in neurones directly involved in energy homeostasis.
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